Developmental and Behavioral Pediatrics Practice Questions

Q: Amongst various treatment modalities for nocturnal enuresis, the relapse rates have been observed to be lowest for:

Bell alarm systems. ***Bell alarm systems*** - **Bell alarm systems** (**enuresis alarms**) work on the principle of classical conditioning, teaching the child to awaken to a full bladder. With long-term use and consistent adherence, they achieve the lowest relapse rates because they address the underlying behavioral and physiological patterns. - These alarms are highly effective in children who have normal bladder capacity but fail to awaken to bladder fullness, leading to a permanent conditioning response. *Oxybutynin* - **Oxybutynin** is an anticholinergic medication that reduces bladder contractility and increases bladder capacity. While it can be effective for some, its use is typically for overactive bladder and not consistently for primary enuresis, and relapse rates can be significant upon discontinuation. - It is often used in combination with other treatments for nocturnal enuresis, especially if there is an underlying detrusor overactivity, but alone it doesn't offer the lowest relapse rates. *Imipramine* - **Imipramine**, a tricyclic antidepressant, works by reducing arousal thresholds during sleep, causing bladder relaxation, and having anticholinergic effects. It is effective in reducing enuretic episodes while on treatment. - However, upon discontinuation, relapse rates are high, often exceeding 50-70%, as it does not address the underlying conditioning for waking up to a full bladder. *Desmopressin* - **Desmopressin** is an antidiuretic hormone analogue that works by reducing nocturnal urine production. It is effective in the short term for reducing bedwetting episodes. - While effective during treatment, its effect is primarily symptomatic, and relapse rates are high once the medication is stopped, as it does not correct the body's natural diurnal rhythm of ADH secretion or train bladder control.

Q: A 7-year-old with nocturnal enuresis has failed behavioral therapy and alarm interventions, and urinalysis is normal. What is the next step in management?

Start desmopressin. ***Start desmopressin*** - **Desmopressin (DDAVP)** is often the next step when behavioral therapy and alarms fail, especially in cases of uncomplicated **nocturnal enuresis** with a normal urinalysis. - It is an **antidiuretic hormone analog** that reduces urine production during the night, thereby decreasing the likelihood of bedwetting. *Initiate anticholinergic therapy* - **Anticholinergics** like oxybutynin are typically reserved for cases where there is evidence of **detrusor overactivity** (e.g., frequent daytime wetting, urgency), which is not indicated here. - These medications help relax the bladder muscle but can have side effects such as **dry mouth** and constipation. *Consider urodynamic studies* - **Urodynamic studies** are generally not indicated for uncomplicated nocturnal enuresis and are reserved for cases with **complex voiding dysfunction**, recurrent UTIs, or suspicion of anatomical abnormalities. - Performing these studies as a next step without other clinical indicators would be **overzealous**. *Refer to a pediatric urologist* - Referral to a **pediatric urologist** is usually considered for children with refractory enuresis, those with suspected underlying anatomical abnormalities, or when other medical treatments have failed. - Given that **pharmacological treatment (desmopressin)** has not yet been attempted, direct referral is premature.

Q: A child presents with bedwetting at night, and urinalysis is normal. What is the next management step?

Behavioral therapy. ***Behavioral therapy*** - **Behavioral therapy**, including **urotherapy** and **bedwetting alarms**, is the first-line treatment for **monosymptomatic nocturnal enuresis** (bedwetting without other lower urinary tract symptoms or underlying medical conditions). - These methods help children recognize and respond to a full bladder during sleep, and success rates can be high with consistent use. - Active behavioral intervention is recommended when a child presents for evaluation, particularly if the condition is affecting the child's self-esteem or quality of life. *Monitor and reassess* - While some cases of enuresis resolve spontaneously (especially in younger children), **active management** with behavioral interventions is the appropriate next step once a child presents for evaluation with **monosymptomatic nocturnal enuresis** after medical causes have been ruled out. - Simply observing without intervention is not considered optimal management when a family seeks help, as behavioral therapies are non-invasive, effective, and can prevent psychosocial impact. *Refer to urology* - **Referral to urology** is generally reserved for cases where there are **red flags** or associated symptoms (e.g., daytime wetting, urgency, frequency, dysuria, recurrent UTIs, abnormal physical examination), suggesting a more complex urological issue. - Since the urinalysis is normal and no other symptoms are mentioned, a urology referral is not the initial next step. *Start desmopressin* - **Desmopressin** is a **pharmacological treatment** often considered after behavioral and lifestyle interventions have been tried and failed, or in situations where a quick temporary response is needed (e.g., sleepovers, camps). - It is not the initial first-line management step for uncomplicated nocturnal enuresis, though it may be used in combination with behavioral therapy in persistent cases.

Q: Which of the following conditions is most commonly associated with regression of developmental milestones?

Rett syndrome. ***Rett syndrome*** - This **neurodevelopmental disorder** almost exclusively affects girls and is characterized by a period of normal development (6-18 months) followed by rapid **regression of acquired fine motor, language, and social skills**. - Hallmark features include **loss of purposeful hand movements** (replaced by characteristic hand-wringing or washing stereotypies), **decelerated head growth**, breathing irregularities, and severe cognitive impairment. - While less common than autism, Rett syndrome is the **most characteristically associated** with developmental regression as a defining diagnostic feature. *Autistic regression* - Refers to a subset (15-40%) of children with autism spectrum disorder who experience loss of previously acquired language or social skills, typically between **18 and 36 months of age**. - While regression occurs, the overall pattern differs: **no characteristic hand stereotypies**, **no decelerated head growth**, and variable outcomes with intervention. *Neuromuscular disorders* - Conditions like spinal muscular atrophy or muscular dystrophies primarily affect **motor function** through progressive weakness. - They cause **loss of motor milestones** but typically do not involve regression of **cognitive, language, or social skills** that characterize Rett syndrome. *Childhood disintegrative disorder* - Rare condition involving regression after at least **2 years of normal development** (later onset than Rett syndrome). - Involves loss across multiple domains but affects **both sexes equally** and lacks the characteristic hand stereotypies and breathing abnormalities of Rett syndrome.

Q: A 2-year-old child, while playing, gets upset after a toy is taken away. The child begins to cry vigorously, then suddenly loses consciousness and appears pale. There is no significant medical history and the child was otherwise healthy. Which of the following is the most probable diagnosis?

Breath holding spell. ***Breath holding spell*** - This condition presents with sudden **loss of consciousness**, often accompanied by **pallor** or cyanosis, in response to an emotional trigger like anger or pain. - It's a common, **benign condition** in young children, occurring in otherwise healthy individuals with no significant medical history. *Autism spectrum disorder* - Characterized by persistent deficits in **social communication** and **interaction**, and restricted, repetitive patterns of behavior, interests, or activities. - It does not involve sudden loss of consciousness or pallor as primary symptoms. *Rett syndrome* - A rare **neurodevelopmental disorder** almost exclusively affecting girls, characterized by normal early development followed by regression in communication, motor skills, and hand movements. - It does not present with sudden episodes of loss of consciousness; rather, it involves a progressive loss of developmental milestones. *Attention deficit hyperactivity disorder* - This is a neurodevelopmental disorder marked by problems with **attention**, **hyperactivity**, and **impulsive behavior**. - It does not involve episodes of sudden loss of consciousness or physical symptoms like pallor.

Q: At what age do children typically recognize their gender identity?

3 years. ***3 years*** - Children typically begin to **recognize and label their own gender identity** and that of others around this age. - At this stage, they understand that they are a boy or a girl, though their understanding of **gender constancy** (that gender doesn't change) is still developing. *1 year* - At this age, infants are developing **basic self-awareness** and starting to recognize themselves as distinct individuals. - However, their cognitive abilities are not yet sufficient for recognizing complex concepts like **gender identity**. *4 years* - While children continue to solidify their understanding of gender around this age, the **initial recognition** usually occurs earlier. - By 4 years, many children also start to develop an understanding of **gender stereotypes**. *5 years* - By this age, most children have a firm grasp of their **gender identity** and have begun to understand **gender constancy**, meaning they know their gender is permanent. - The initial recognition and labeling of gender identity usually happens a couple of years before this.

Q: At what age does stranger anxiety typically develop in infants?

7 months. ***7 months*** - **Stranger anxiety** typically emerges around **6-8 months** of age, peaking around 9-12 months. - This developmental stage reflects the infant's growing ability to distinguish between familiar and unfamiliar faces and their developing **attachment to primary caregivers**. *3 months* - At 3 months, infants are typically in an earlier stage of social development, primarily focusing on **recognizing primary caregivers** and showing social smiles. - They generally do not exhibit stranger anxiety, as their cognitive and emotional development has not yet reached that milestone. *4 months* - While 4-month-olds are becoming more socially aware and responsive, their **object permanence** and ability to differentiate strangers from familiar faces is still developing. - Therefore, definitive stranger anxiety is typically not observed at this age. *11 months* - By 11 months, stranger anxiety has already developed and is usually **at its peak**, as infants at this age have a well-established sense of who their primary caregivers are. - While stranger anxiety is very prominent at this age, it is not when it typically **develops** (initial emergence), but rather when it is most pronounced.

Q: Which of the following is NOT a treatment option for nocturnal enuresis?

Immediate surgical intervention. ***Immediate surgical intervention*** - **Nocturnal enuresis** is primarily managed with conservative measures or medication; surgical intervention is almost never indicated unless there is an underlying anatomical defect causing the enuresis, which is rare. - This is an **invasive approach** typically reserved for structural abnormalities of the urinary tract, not for functional enuresis. *Imipramine* - **Imipramine**, a tricyclic antidepressant, is sometimes used for nocturnal enuresis due to its anticholinergic and alpha-adrenergic effects, which can increase **bladder capacity** and reduce bladder contractions. - It's considered a secondary pharmacological option when other first-line treatments are insufficient. *Behavioral therapy with alarm setup* - **Bedwetting alarms** are a highly effective first-line treatment, working on conditioning principles to train the child to wake up when bladder sensation occurs. - This behavioural approach is focused on teaching the child to recognize a full bladder and to respond to it. *Voiding of urine before sleeping* - **Scheduled voiding**, particularly just before bedtime, is a common and simple behavioral modification that can help reduce the frequency of nocturnal enuresis episodes. - This strategy aims to ensure the bladder is as empty as possible at the start of the sleep cycle.

Q: What is the treatment of choice for a 5-year-old child with bedwetting?

Motivational therapy. ***Motivational therapy*** - This is the **first-line active treatment** for **primary nocturnal enuresis** in children, involving encouragement, positive reinforcement (star charts), rewards, and education about bladder control. - It focuses on **behavioral strategies** and can be highly effective with parental involvement. - When intervention is pursued at age 5, motivational therapy is preferred over pharmacological options due to safety and effectiveness. *No treatment* - At age 5, **watchful waiting with reassurance** is often appropriate since nocturnal enuresis is common at this age (affects 15-20% of 5-year-olds) and has a **spontaneous resolution rate of 15% per year**. - However, when the question asks for "treatment of choice," it implies active intervention rather than observation alone. - Active behavioral therapy is preferred when bedwetting causes distress or affects the child's self-esteem. *Imipramine* - **Imipramine** is a **tricyclic antidepressant** with anticholinergic effects that can reduce bladder contractions, but it has significant side effects including **cardiac arrhythmias** and is **not first-line treatment**. - It is typically reserved for children ≥7 years after behavioral interventions fail, due to its potential adverse effects and high relapse rate after discontinuation. *Desmopressin* - **Desmopressin** is an **antidiuretic hormone analog** that reduces urine production overnight. - While effective, it is typically reserved for children ≥6 years who are unresponsive to behavioral therapy or for **short-term situational use** (e.g., sleepovers, camps). - Side effects include potential **hyponatremia** and high relapse rate after discontinuation.

Q: In which condition is a stimulant drug commonly prescribed for children?

Attention Deficit Hyperactivity Disorder (ADHD). ***Attention Deficit Hyperactivity Disorder (ADHD)*** - **Stimulant medications** (methylphenidate, amphetamines) are the **first-line pharmacologic treatment** for ADHD in children and represent the **most common indication** for stimulant use in pediatrics. - These drugs improve **focus**, reduce **hyperactivity**, and decrease **impulsivity** by increasing **dopamine** and **norepinephrine** levels in the brain. - ADHD affects approximately **5-10% of children**, making stimulant prescriptions extremely common in pediatric practice. *Narcolepsy* - While stimulants (methylphenidate, modafinil) are **indicated** for pediatric narcolepsy to treat excessive daytime sleepiness, this condition is **rare in children** (prevalence <0.05%). - Narcolepsy typically presents with **irresistible sleep attacks**, **cataplexy** (sudden muscle weakness with emotions), and other features. - Though stimulants are appropriate treatment, the **low prevalence** makes this a much less common indication than ADHD. *Obstructive Sleep Apnea* - Primary treatment involves addressing the **airway obstruction** through **adenotonsillectomy** in children or **CPAP** therapy. - **Stimulants are not indicated** for OSA and could potentially worsen cardiovascular complications. - Treating the underlying sleep disorder is essential, not masking daytime sleepiness with stimulants. *Conduct Disorder* - Characterized by **persistent aggressive and defiant behaviors** violating societal norms. - Primary treatment is **psychotherapy** and **behavioral interventions**, not pharmacotherapy. - Stimulants are **not effective** for core conduct disorder symptoms unless there is **comorbid ADHD**.

Question 1

Amongst various treatment modalities for nocturnal enuresis, the relapse rates have been observed to be lowest for:

Accepted Answer

Bell alarm systems

Answer

Oxybutynin

Answer

Imipramine

Answer

Desmopressin

Question 2

A 7-year-old with nocturnal enuresis has failed behavioral therapy and alarm interventions, and urinalysis is normal. What is the next step in management?

Accepted Answer

Start desmopressin

Answer

Initiate anticholinergic therapy

Answer

Consider urodynamic studies

Answer

Refer to a pediatric urologist

Question 3

A child presents with bedwetting at night, and urinalysis is normal. What is the next management step?

Accepted Answer

Behavioral therapy

Answer

Monitor and reassess

Answer

Refer to urology

Answer

Start desmopressin

Question 4

Which of the following conditions is most commonly associated with regression of developmental milestones?

Accepted Answer

Rett syndrome

Answer

Autistic regression

Answer

Neuromuscular disorders

Answer

Childhood disintegrative disorder

Question 5

A 2-year-old child, while playing, gets upset after a toy is taken away. The child begins to cry vigorously, then suddenly loses consciousness and appears pale. There is no significant medical history and the child was otherwise healthy. Which of the following is the most probable diagnosis?

Accepted Answer

Breath holding spell

Answer

Autism spectrum disorder

Answer

Rett syndrome

Answer

Attention deficit hyperactivity disorder

Question 6

At what age do children typically recognize their gender identity?

Accepted Answer

3 years

Answer

4 years

Answer

1 year

Answer

5 years

Question 7

At what age does stranger anxiety typically develop in infants?

Accepted Answer

7 months

Answer

3 months

Answer

4 months

Answer

11 months

Question 8

Which of the following is NOT a treatment option for nocturnal enuresis?

Accepted Answer

Immediate surgical intervention

Answer

Imipramine

Answer

Behavioral therapy with alarm setup

Answer

Voiding of urine before sleeping

Question 9

What is the treatment of choice for a 5-year-old child with bedwetting?

Accepted Answer

Motivational therapy

Answer

No treatment

Answer

Imipramine

Answer

Desmopressin

Question 10

In which condition is a stimulant drug commonly prescribed for children?

Accepted Answer

Attention Deficit Hyperactivity Disorder (ADHD)

Answer

Obstructive Sleep Apnea

Answer

Conduct Disorder

Answer

Narcolepsy

Developmental and Behavioral Pediatrics — MCQs

Developmental and Behavioral Pediatrics — MCQs

On this page

Practice by Chapter

Want unlimited practice?